Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Tables)

v3.10.0.1
Stock Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense (options, and restricted share grants) in its condensed consolidated statements of operations as follows ($ and shares in thousands):

 

    Three Months Ended
September 30, 		    Nine Months Ended
September 30, 		 
    2018     2017     2018     2017  
                         
Research and Development   $ 101     $ 280     $ 787     $ 785  
General and Administrative     404       271       2,016       1,454  
Total   $ 505     $ 551     $ 2,803     $ 2,239  

Schedule of Equity Compensation Plan by Arrangements

    Reserved           Awards  
    for     Awards     Available  
    Issuance     Issued     for Grant  
2013 Equity Compensation Plan     17,890       13,000 *     4,890  
                         

 

* includes both restricted stock grants and option grants
Schedule of Stock Option Activity

The following table summarizes the Company’ stock option activity and related information for the period from December 31, 2017 to September 30, 2018 (number of options in thousands):

 

          Weighted  
    Number of     Average  
    Options     Exercise Price  
Outstanding at December 31, 2017     11,433     $ 1.40  
Granted     2,032       0.77  
Forfeited     1,013       2.31  
Cancelled     997       1.31  
Outstanding at September 30, 2018     11,455     $ 1.21  

Schedule of Share Based Payment Assumptions

The following weighted-average assumptions were used to calculate share based compensation for the three months and nine months ended September 30, 2018 and 2017:

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30,     September 30,  
    2018     2017     2018     2017  
Volatility     105.85-109.95 %     67.09%-70.70 %     105.85-109.95 %     67.09%-82.26 %
Risk-free interest rate     2.84-3.00 %     2.015%-2.75 %     2.29-3.00 %     1.89%-2.22 %
Dividend yield     0.0 %     0.0 %     0.0 %     0.0 %
Expected life     6.0 years       6.0 years       6.0 years       6.0 years  

Schedule of Unvested Restricted Stock Grant Activity

Detailed below is the restricted stock grant activity since the inception of the Company through September 30, 2018:

 

    Shares     Expense     Weighted Average Grant Date Fair Value     Weighted Average Remaining Term (years)  
Unvested at December 31, 2017     -       -       -       -  
Granted     713,266     $ 534,804       0.75          
Vested     521,044     $ 413,704       0.79          
Forfeited     -     $ -       -          
Unvested at September 30, 2018     192,222     $ 121,100       0.63       0.5